Saturday, November 2, 2019
7:00 AM- 7:45 AM
Breakfast
Alternative Breakfast: Diversity in Leadership Meeting (Open to all participants)
8:00 AM - 11:45 PM
Opening Session
CNS Summit 2019 Keynote Session
Jessica Mega, Chief Medical & Scientific Officer, Verily
Reed Tuckson, Managing Director, Tuckson Health Connections
Amir Kalali, Chief Curator, CNS Summit
Mona Siddiqui, Chief Data Officer, Dept. of Health and Human Services (HHS)
Naveen Rao, GM, Artificial Intelligence Products Group, Intel
Antony Loebel, President & CEO, Sunovion
Rob Scott, Chief Medical Officer, Abbvie
Glen de Vries, President, Medidata
Gil Bashe, Managing Partner, Global Health, Finn Partners
Pravin Jadhav, Sr. Director, Innovation and Business Transformation, Corporate Projects, Otsuka Pharmaceuticals
Robert Hariri, Founder, Chairman & CEO, Celularity Inc.
Spyros Papapetropoulos, Dept of Neurology, MGH
Deborah Scher, Executive Advisor to the Secretary, US Department of Veterans Affairs
Jennifer Goldsack, Interim Executive Director, Digital Medicine Society (DiMe)
Andy Coravos, Co-founder & CEO, Elektra Labs
Crystal Ball Session:
Don Jones, CDO, Scripps
Glen de Vries, President, Medidata
Michelle Longmire, CEO, Medable
Mike Rea, CEO, IDEA Pharma
Steve Rosenberg, SVP and GM, Oracle Health Sciences
Cynthia Verst, President, R&DS Design & Delivery Innovation, IQVIA
Taren Grom, Editor-in-Chief, PharmaVoice
Rob Wright, Editor-in-Chief, Life Science Leaders
Jamie Macdonald, CEO, Parexel
Andy Coravos, CEO, Elektra Labs
Rob Scott, Chief Medical Officer, Abbvie
Pavan Cheruvu, CEO, Axovant
11:45 pm- 12:30 pm
Innovation Showcase
Kate Hermans, Chief Business Officer for Pharma, 83bar
David Kiger, Chief Commercial Officer, Datacubed Health
Michal Rys, Co-Founder & CEO, Dr0mnibus
Meghan Conroy, CEO & Founder, CaptureProof
Hosted by Daniel Chui, GSK & Georgia Mitsi, Sunovion
12:30 pm- 1:00 pm
Lunch (provided)
1:00 pm- 3:00 pm
CNS Summit Spotlight Sessions:
Spotlight: Decentralized Trials: Where Does the Industry Stand? 1-2pm
Leslie Shinobu, Portfolio Transformation Team, Biogen
&nnbsp; Susan Wong, Sr Director, Strategic & Clinical Operations, Transparency Life Sciences
Vishall Mehra, CEO & Medical Director, Artemis Institute for Clinical Research
Chair: Katherine Vandebelt, Global Head of Clinical Innovation, Oracle Health Sciences
Spotlight: Decentralized Trials 2-3pm
Michelle Longmire, CEO, Medable
Josh Rose, Global Head Virtual Trial Operations, IQVIA
John Reites, Chief Product Officer, THREAD
Anthony Costello, SVP, Medidata
Jonathan Cotliar, Chief Medical Officer, Science37
Chair: Craig Lipset, Founder & Advisor, Clinical Innovation Partners
Spotlight: Neuroscience 1-3pm
Jonas Hannestad, VP Clinical Development, Alkahest
Volker Knappertz, Chief Medical Officer, GW Pharmaceuticals
Roger Crystal, CEO, Opiant
Randall Owen, Chief Medical Officer, Navitor Pharma
Chad Beyer, Senior Vice President, Research & Development, Promentis Pharmaceuticals
Clare Stroud, Director, Neuroscience & Nervous System, NASEM
Carla Canuso, Sr. Director, Clinical Development, J&J
Co-Chair: Atul Mahableshwarkar, Sr Vice President, Research & Development, Emalex Biosciences
Co-Chair: Roger Bullock, Chief Medical Officer, Oryzon Genomics
Spotlight: Voice as an Endpoint in Clinical Trials 1-2pm
Visar Berisha, Co-Founder, Chief Analytics Officer, Aural Analytics
Zheng Yang, Head of Technology & Data Innovation, BI
Michael Gold, VP, Development Neurosciences, AbbVie
Pravin Jadhav, R&D Innovation, Otsuka
Chair: Daniel Jones, CEO & Co-Founder, Aural Analytics
Spotlight: Uncommon Solutions to Common Challenges in Rare Diseases 2-3pm
Bola Oyegunwa, VP & Head of Virtual Trials, Covance
Dekel Gelbman, CEO, FDNA
Dina Katabi, Professor, MIT
Chair: Cindy Jackson, VP & GM, Rare Diseases & Pediatrics, Covance
Spotlight: DTx VR AR XR: Why Should Life Science Companies Care? 1-2pm
Walter Greenleaf, Medical VR/AR Expert, Stanford University
Brennan Spiegel, Director of Health Services Research, Cedars-Sinai
Chair: Joe Powers, Chief Strategy Officer, AppliedVR
Spotlight: Putting the Patient First with Predictive Analytics and Smarter eCOA 2-3pm
Steve Brannan, Chief Medical Officer, Karuna Therapeutics
Todd Solomon, Director Clinical Development, Avanir
Dan DeBonis, Principal, Endpoint Solutions, Signant Health
Gary Sachs, Clinical Vice President, Signant Health
Chair: Mike Nolte, CEO, Signant Health
Spotlight: The STARR Coalition: Ethics in Person-Centered CNS Research: Completing the Circle of Care 2-3pm
Luke Kramer, Executive Director, The STARR Coalition
Kim Vanover, SVP, Intra-Cellular Therapies
Cecilia McGough, CEO, Students with Schizophrenia
Corey Fowler, Associate Director, Global Clinical Development, Otsuka
William Martin, Senior Director, Clinical Development, Alkermes
Krista Armstrong, SVP, Head of Neuroscience, Premier Research
Leslie Franceschi, Sr. Project Director, CNS Clinical Development, Syneos Health
Innovation Showcase Updates 1-2pm
Matthew Stoudt, CEO, AppliedVR
Benjamin Vandendriessche, CMO, Byteflies
Carrie Burke, VP, Business Development & Partnerships, Clinithink
Francois Torche, CEO, Cluepoints
Adam Hanina, CEO, AiCure
Don Jones, Board Member, Seqster
Chair: Spyros Papapetropoulos, Dept of Neurology, MGH
3:30 pm- 5:00 pm
One-to-One Networking Sessions
5:00 pm- 7:00 pm
Evening Reception, Posters & Exhibits